Jupiter Acquisition Corporation (JAQC)
Price:
10.34 USD
( + 0.00 USD)
Your position:
0 USD
ACTION PANEL
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Churchill Capital Corp X
VALUE SCORE:
7
2nd position
Range Capital Acquisition Corp.
VALUE SCORE:
10
The best
M3-Brigade Acquisition V Corp. Units
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
No data to display
No data to display
No data to display
DESCRIPTION
Jupiter Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Hobe Sound, Florida.
NEWS
Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public Shares
globenewswire.com
2023-12-19 23:30:00Hobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced the mutually agreed termination of the previously announced business combination agreement with Filament Health Corp. (the “Business Combination Agreement”). The special meeting of stockholders of Jupiter scheduled to reconvene on Thursday, December 28, 2023, at 12:00 p.m. Eastern Time, at which stockholders of Jupiter were to be asked to vote to approve the Business Combination Agreement and the business combination contemplated thereby, among other related matters, has been cancelled.
Jupiter Acquisition Corporation Announces Intent to Reconvene and Adjourn its Special Meeting of Stockholders to December 18, 2023
globenewswire.com
2023-12-12 08:00:00Hobe Sound, FL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to reconvene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the “Business Combination Special Meeting”) scheduled to reconvene on Tuesday, December 12, 2023, at 12:00 p.m. Eastern Time, until Monday, December 18, 2023, at 12:00 p.m. Eastern Time, as a completely virtual meeting conducted via live webcast, which will be available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the Business Combination Special Meeting, once further reconvened, stockholders of Jupiter will be asked to vote on the proposals described in the definitive proxy statement/prospectus filed by Jupiter with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023 (as further amended or supplemented, the “definitive proxy statement/prospectus”), relating to the proposed business combination (the “Proposed Business Combination”) between Jupiter and Filament Health Corp., a corporation organized under the laws of British Columbia (“Filament”).
Jupiter Acquisition Corporation Announces Intent to Convene and Adjourn its Special Meeting of Stockholders to December 12, 2023
globenewswire.com
2023-12-04 16:45:00Hobe Sound, FL, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to convene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the “special meeting”) scheduled to occur on Tuesday, December 5, 2023, at 12:00 p.m. Eastern Time, until Tuesday, December 12, 2023, at 12:00 p.m. Eastern Time, as a completely virtual meeting conducted via live webcast, which will be available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the special meeting, once reconvened, stockholders of Jupiter will be asked to vote on the proposals described in the definitive proxy statement/prospectus filed by Jupiter with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023, relating to the proposed business combination (the “Proposed Business Combination”) between Jupiter and Filament Health Corp., a corporation organized under the laws of British Columbia (“Filament”).
No data to display
Jupiter Acquisition Corporation Announces Mutually Agreed Termination of Business Combination Agreement With Filament Health Corp., Cancellation of Special Meeting of Stockholders and Redemption of Public Shares
globenewswire.com
2023-12-19 23:30:00Hobe Sound, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced the mutually agreed termination of the previously announced business combination agreement with Filament Health Corp. (the “Business Combination Agreement”). The special meeting of stockholders of Jupiter scheduled to reconvene on Thursday, December 28, 2023, at 12:00 p.m. Eastern Time, at which stockholders of Jupiter were to be asked to vote to approve the Business Combination Agreement and the business combination contemplated thereby, among other related matters, has been cancelled.
Jupiter Acquisition Corporation Announces Intent to Reconvene and Adjourn its Special Meeting of Stockholders to December 18, 2023
globenewswire.com
2023-12-12 08:00:00Hobe Sound, FL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to reconvene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the “Business Combination Special Meeting”) scheduled to reconvene on Tuesday, December 12, 2023, at 12:00 p.m. Eastern Time, until Monday, December 18, 2023, at 12:00 p.m. Eastern Time, as a completely virtual meeting conducted via live webcast, which will be available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the Business Combination Special Meeting, once further reconvened, stockholders of Jupiter will be asked to vote on the proposals described in the definitive proxy statement/prospectus filed by Jupiter with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023 (as further amended or supplemented, the “definitive proxy statement/prospectus”), relating to the proposed business combination (the “Proposed Business Combination”) between Jupiter and Filament Health Corp., a corporation organized under the laws of British Columbia (“Filament”).
Jupiter Acquisition Corporation Announces Intent to Convene and Adjourn its Special Meeting of Stockholders to December 12, 2023
globenewswire.com
2023-12-04 16:45:00Hobe Sound, FL, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today announced that it intends to convene and then adjourn, without conducting any business, the special meeting of stockholders of Jupiter (the “special meeting”) scheduled to occur on Tuesday, December 5, 2023, at 12:00 p.m. Eastern Time, until Tuesday, December 12, 2023, at 12:00 p.m. Eastern Time, as a completely virtual meeting conducted via live webcast, which will be available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the special meeting, once reconvened, stockholders of Jupiter will be asked to vote on the proposals described in the definitive proxy statement/prospectus filed by Jupiter with the U.S. Securities and Exchange Commission (the “SEC”) on November 13, 2023, relating to the proposed business combination (the “Proposed Business Combination”) between Jupiter and Filament Health Corp., a corporation organized under the laws of British Columbia (“Filament”).